BIXT Bioxytran, Inc.

Fundamentals / CIK 0001445815 / USD

Bioxytran, Inc. reported $245K in total assets and a net loss of $4.49M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BIXT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$715K$358K$0-$4.20MFY 2016 Revenue: $246KFY 2016 Net Income: -$697K2016FY 2017 Revenue: $191KFY 2017 Net Income: -$318K2017FY 2018 Net Income: -$296K2018FY 2019 Net Income: -$1.86M2019FY 2020 Net Income: -$2.54M2020FY 2021 Net Income: -$4.03M2021FY 2022 Net Income: -$2.46M2022FY 2023 Net Income: -$4.47M2023FY 2024 Net Income: -$2.37M2024FY 2025 Net Income: -$2.12M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- -- -- -- $191K $246K
Cost of Revenue -- -- -- -- -- -- -- -- $104K $96K
Gross Profit -- -- -- -- -- -- -- -- $87K $150K
Research & Development $454K $112K $1.15M $978K $2.01M $545K -- -- -- --
Selling, General & Admin -- -- -- -- -- -- -- -- $398K $821K
Total Operating Expenses $1.84M $2.22M $3.80M $2.13M $4.21M $1.27M $1.63M $215K $398K $821K
Operating Income -$1.84M -$2.22M -$3.80M -$2.13M -$4.21M -$1.27M -$1.63M -$215K -$311K -$671K
EBITDA -- -- -- -- -- -- -- -- -$293K -$644K
Interest Expense $134K $84K $193K -- $2.02M $1.01M $42K $3.7K $7.8K $7.8K
Income Before Tax -$2.12M -$2.38M -$4.56M -$2.66M -$4.53M -$2.54M -$1.86M -$296K -- -$697K
Income Tax Expense -- -- -- -- -- -- -- $400 -- --
Net Income -$2.12M -$2.37M -$4.47M -$2.46M -$4.03M -$2.54M -$1.86M -$296K -$318K -$697K
Basic EPS -$0.02 -$0.02 -$0.03 -$0.02 -$0.04 -$0.03 -$0.02 $0.00 -$0.01 -$0.03
Diluted EPS -$0.02 -$0.02 -$0.03 -$0.02 -$0.04 -$0.03 -$0.02 $0.00 -$0.01 -$0.03
Basic Shares Outstanding 91.8M 138.6M 134.0M 115.1M 106.3M 94.0M 85.6M 85.1M 39.5M 26.5M
Diluted Shares Outstanding 91.8M 138.6M 134.0M 115.1M 106.3M 94.0M 85.6M 85.1M 39.5M 26.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development -- $255K $225K $2.0K $0 $102K $350K $34K
Total Operating Expenses $203K $655K $1.93M $607K $496K $224K $515K $488K
Operating Income -$203K -$655K -$1.93M -$607K -$496K -$224K -$515K -$488K
Interest Expense $37K $36K $36K $37K $37K $30K $31K $20K
Income Before Tax -$1.28M -$620K -$2.07M -$522K -$283K $35K -$1.35M -$752K
Net Income -$1.28M -$620K -$2.07M -$522K -$283K $35K -$1.35M -$752K
Basic EPS $0.00 -$0.01 -$0.02 -- $0.00 $0.00 -$0.02 --
Diluted EPS $0.00 -$0.01 -$0.02 -- $0.00 $0.00 -$0.02 --
Basic Shares Outstanding 114.7M 114.4M 112.3M -- 89.0M 88.8M 88.8M --
Diluted Shares Outstanding 114.7M 114.4M 112.3M -- 89.0M 88.8M 88.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $510K $5.2K $26K $295K $72K $42K $170K $36K $110 $11K
Cash & Short-Term Investments $510K $5.2K $26K $295K $72K $42K $170K $36K $110 $11K
Accounts Receivable, Net -- -- -- -- -- -- $50K -- $23K $9.6K
Inventory -- -- -- -- -- -- -- -- $5.3K $6.3K
Total Current Assets $513K $5.2K $26K $295K $72K $316K $220K $36K $110 $27K
Property, Plant & Equipment, Net -- -- -- -- -- -- -- -- $682K $25K
Intangible Assets $145K $134K $113K $76K $47K $10K -- -- -- --
Total Non-Current Assets $145K $134K $112K $76K $47K $10K $0 $0 $0 $25K
Total Assets $659K $139K $139K $371K $119K $326K $220K $36K $110 $52K
Accounts Payable -- -- -- $710K -- -- -- -- -- --
Short-Term Debt -- $48K -- -- -- -- -- -- $25K --
Deferred Revenue (Current) -- -- -- -- -- -- -- -- $4.8K --
Other Current Liabilities -- -- -- $710K -- -- -- -- -- --
Total Current Liabilities $3.25M $1.93M $3.24M $3.66M $3.28M $2.27M $1.02M $262K $1.4K $342K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $3.25M $1.93M $3.24M $3.66M $3.28M $2.27M $1.02M $262K $1.4K $342K
Total Debt (incl. Leases) -- $48K -- -- -- -- -- -- $25K --
Common Stock $108K $87K $145K $123K $111K $97K $86K $85K $85K $28K
Retained Earnings -$21.04M -$18.92M -$15.70M -$11.22M -$8.75M -$4.72M -$2.24M -$383K -$86K -$13.88M
Total Stockholders' Equity -$2.59M -$1.79M -- -- -$3.16M -$1.94M -$799K -$225K -$1.3K -$291K
Total Equity -$2.59M -$1.79M -$3.10M -$3.30M -$3.16M -$1.94M -$799K -$225K -$1.3K -$291K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $74K $177K $463K $510K $14K $3.1K $4.3K $5.2K
Cash & Short-Term Investments $74K $177K $463K $510K $14K $3.1K $4.3K $5.2K
Total Current Assets $74K $177K $463K $513K $14K $3.1K $4.3K $5.2K
Intangible Assets $170K $156K $152K $145K $142K $144K $132K $134K
Total Non-Current Assets $170K $156K $152K $145K $142K $144K $132K $134K
Total Assets $245K $333K $615K $659K $156K $148K $136K $139K
Short-Term Debt -- -- -- -- -- $48K $48K $48K
Total Current Liabilities $6.46M $5.27M $5.01M $3.25M $3.06M $2.78M $2.84M $1.93M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $6.46M $5.27M $5.01M $3.25M $3.06M $2.78M $2.84M $1.93M
Total Debt (incl. Leases) -- -- -- -- -- $48K $48K $48K
Common Stock $115K $115K $113K $108K $89K $89K $89K $87K
Retained Earnings -$25.01M -$23.73M -$23.11M -$21.04M -$20.52M -$20.24M -$20.27M -$18.92M
Total Stockholders' Equity -$6.21M -$4.94M -$4.39M -$2.59M -$2.90M -$2.64M -$2.71M -$1.79M
Total Equity -$6.21M -$4.94M -$4.39M -$2.59M -$2.90M -$2.64M -$2.71M -$1.79M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$2.12M -$2.38M -$4.56M -$2.66M -$4.53M -$2.48M -$1.86M -$296K -$318K -$697K
Depreciation & Amortization -- -- -- -- -- -- -- -- $18K $28K
Stock-Based Compensation $197K $634K $198K $178K $583K $248K $1.12M -- -- --
Change in Receivables -- -- -- -- -- -- -- -- -$13K -$9.6K
Change in Inventory -- -- -- -- -- -- -- -- $1.0K -$6.3K
Operating Cash Flow -$526K -$381K -$775K -$1.81M -$1.70M -$1.10M -$431K -$186K -$19K -$42K
Investing Cash Flow -$23K -$28K -$44K -$32K -$37K -$10K -- -- -- --
Common Stock Issued $439K $63K $550K -- $600K $600K $20K -- -- $50K
Financing Cash Flow $1.05M $389K $550K $2.06M $1.76M $981K $564K $222K $23K $50K
Net Change in Cash $505K -$21K -$269K $223K $31K -$128K $133K $36K $4.2K $7.6K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.28M -$620K -$2.07M -$522K -$283K $35K -$1.35M -$752K
Stock-Based Compensation $11K $7.8K $1.29M $85K $44K $42K $27K $229K
Operating Cash Flow -$92K -$350K -$239K -$237K -$49K -$73K -$167K -$128K
Investing Cash Flow -$19K -$9.4K -$9.2K -$6.2K -$4.2K -$13K -$15 -$12K
Common Stock Issued $0 $45K $146K -- -- -- -- $0
Financing Cash Flow $7.9K $73K $201K $739K $65K $85K $167K $110K
Net Change in Cash -$103K -$286K -$47K $495K $11K -$1.2K -$806 -$30K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- -- -- 45.6% 60.9%
Operating Margin -- -- -- -- -- -- -- -- -162.5% -272.3%
Net Profit Margin -- -- -- -- -- -- -- -- -166.6% -282.7%
Return on Assets (ROA) -322.4% -1706.4% -3208.8% -664.2% -3379.8% -779.0% -846.2% -814.1% -289442.7% -1348.4%
Current Ratio 0.16x 0.00x 0.01x 0.08x 0.02x 0.14x 0.22x 0.14x 0.08x 0.08x
Quick Ratio 0.16x 0.00x 0.01x 0.08x 0.02x 0.02x 0.22x 0.14x -3.63x 0.06x
Revenue Growth (YoY) -- -- -- -- -- -- -- -- -22.5% -3.6%
Gross Profit Growth (YoY) -- -- -- -- -- -- -- -- -42.0% +25.0%
5Y Revenue / Share Growth -- -- -- -- -- -- -- -- +104.0% +758.1%

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Assets (ROA) -1833.9% -1048.0% -461.3% -322.4% -1505.5% -1669.6% -2322.5% -1706.4%
Current Ratio 0.01x 0.03x 0.09x 0.16x 0.00x 0.00x 0.00x 0.00x
Quick Ratio 0.01x 0.03x 0.09x 0.16x 0.00x 0.00x 0.00x 0.00x
Net Income Growth (YoY) -- -1849.3% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001445815) · from December 31, 2009 Data through September 30, 2026 · synced Nov 21, 2026, 05:11 UTC · Open in terminal